Results
|
741.
|
Identification and characterization of an alternative cancer-derived PD-L1 splice variant. [electronic resource] by
- Hassounah, Nadia B
- Malladi, Venkat S
- Huang, Yi
- Freeman, Samuel S
- Beauchamp, Ellen M
- Koyama, Shohei
- Souders, Nicholas
- Martin, Sunil
- Dranoff, Glenn
- Wong, Kwok-Kin
- Pedamallu, Chandra S
- Hammerman, Peter S
- Akbay, Esra A
Producer: 20190328
In:
Cancer immunology, immunotherapy : CII vol. 68
Availability: No items available.
|
|
742.
|
|
|
743.
|
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. [electronic resource] by
- Conroy, Jeffrey M
- Pabla, Sarabjot
- Nesline, Mary K
- Glenn, Sean T
- Papanicolau-Sengos, Antonios
- Burgher, Blake
- Andreas, Jonathan
- Giamo, Vincent
- Wang, Yirong
- Lenzo, Felicia L
- Bshara, Wiam
- Khalil, Maya
- Dy, Grace K
- Madden, Katherine G
- Shirai, Keisuke
- Dragnev, Konstantin
- Tafe, Laura J
- Zhu, Jason
- Labriola, Matthew
- Marin, Daniele
- McCall, Shannon J
- Clarke, Jeffrey
- George, Daniel J
- Zhang, Tian
- Zibelman, Matthew
- Ghatalia, Pooja
- Araujo-Fernandez, Isabel
- de la Cruz-Merino, Luis
- Singavi, Arun
- George, Ben
- MacKinnon, Alexander C
- Thompson, Jonathan
- Singh, Rajbir
- Jacob, Robin
- Kasuganti, Deepa
- Shah, Neel
- Day, Roger
- Galluzzi, Lorenzo
- Gardner, Mark
- Morrison, Carl
Producer: 20200401
In:
Journal for immunotherapy of cancer vol. 7
Availability: No items available.
|
|
744.
|
|
|
745.
|
|
|
746.
|
|
|
747.
|
|
|
748.
|
|
|
749.
|
|
|
750.
|
|
|
751.
|
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers. [electronic resource] by
- Rofi, Eleonora
- Del Re, Marzia
- Arrigoni, Elena
- Rizzo, Mimma
- Fontanelli, Lorenzo
- Crucitta, Stefania
- Gianfilippo, Giulia
- Restante, Giuliana
- Fogli, Stefano
- Porta, Camillo
- Danesi, Romano
- Schmidinger, Manuela
Producer: 20200207
In:
Critical reviews in oncology/hematology vol. 144
Availability: No items available.
|
|
752.
|
|
|
753.
|
NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy. [electronic resource] by
- Xu, Xian
- Yang, Yang
- Liu, Xiaoyan
- Cao, Na
- Zhang, Peng
- Zhao, Songhui
- Chen, Donglin
- Li, Li
- He, Yong
- Dong, Xiaowei
- Wang, Kai
- Lin, Hanqing
- Mao, Naiquan
- Liu, Lingxiang
Producer: 20210618
In:
The oncologist vol. 25
Availability: No items available.
|
|
754.
|
|
|
755.
|
|
|
756.
|
|
|
757.
|
|
|
758.
|
|
|
759.
|
|
|
760.
|
|